Journal of Isfahan Medical School

Journal of Isfahan Medical School

Evaluation of the Effects of Probiotics on Incidence of Ventilator-Associated Pneumonia in Patients Hospitalized in Intensive Care Unit

Document Type : Original Article (s)

Authors
Mohammad Golparvar 1
Fereshteh Raoufi 2
1 Professor, Department of Anesthesiology, School of Medicine AND Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
10.22122/jims.v37i529.11841
Abstract
Background: Ventilator-associated pneumonia (VAP) is an important hospital infection. Supportive treatments along with antibiotic therapies play a pivotal role in VAP treatments. Studies have showed that probiotics are efficient in preventing different infections. In this study, we aimed to have a survey on possible role of probiotics in prevention of VAP in intensive care unit (ICU).Methods: This was a double-blinded clinical trial study on 126 patients admitted in ICU in Kashani hospital, Isfahan, Iran. Patients were divided into two groups and treated with probiotics and placebo. Data related to VAP incidence were collected and analyzed.Findings: Incidence of VAP was significantly lower in patients who used lactocare as probiotics than in placebo group. Other factors that played roles in VAP such as blood pH, partial pressure of carbon dioxide (PCO2), white blood cell (WBC) count, and neutrophils percent were significantly in better range in patients under probiotic treatments.Conclusion: Generally, we indicated that probiotic usage is associated with decreased VAP and better results for blood pH, PCO2, WBC count, and neutrophils percent in ICU patients. We suggest that physicians pay much attention to probiotic usage in ICU patients and those in danger of VAP.
Keywords
Pneumonia
Ventilator-associated pneumonia
Probiotics
  1. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63(5): e61-e111.
  2. Ekren PK, Ranzani OT, Ceccato A, Li BG, Munoz CE, Ferrer M, et al. Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU. Am J Respir Crit Care Med 2018; 197(6): 826-30.
  3. Bouadma L, Sonneville R, Garrouste-Org, Darmon M, Souweine B, Voiriot G, et al. Ventilator-associated events: Prevalence, outcome, and relationship with ventilator-associated pneumonia. Crit Care Med 2015; 43(9): 1798-806.
  4. Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care 2014; 18(2): 208.
  5. Lawal O, Muhamadali H, Ahmed WM, White IR, Nijsen TME, Goodacre R, et al. Headspace volatile organic compounds from bacteria implicated in ventilator-associated pneumonia analysed by TD-GC/MS. J Breath Res 2018; 12(2): 026002.
  6. Valachis A, Samonis G, Kofteridis DP. The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: A systematic review and metaanalysis. Crit Care Med 2015; 43(3): 527-33.
  7. Nair GB, Niederman MS. Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Med 2015; 41(1): 34-48.
  8. Metersky ML, Wang Y, Klompas M, Eckenrode S, Bakullari A, Eldridge N. Trend in ventilator-associated pneumonia rates between 2005 and 2013. JAMA 2016; 316(22): 2427-9.
  9. Mariyaselvam MZ, Marsh LL, Bamford S, Smith A, Wise MP, Williams DW. Endotracheal tubes and fluid aspiration: an in vitro evaluation of new cuff technologies. BMC Anesthesiol 2017; 17(1): 36.
  10. de Carvalho Baptista IM, Martinho FC, Nascimento GG, da Rocha Santos CE, Prado RFD, Valera MC. Colonization of oropharynx and lower respiratory tract in critical patients: Risk of ventilator-associated pneumonia. Arch Oral Biol 2018; 85: 64-9.
  11. Fawzy M, Genena D, Sewify K. Should probiotics be routinely used in critically Ill patients? BAOJ Nutrition 2017; 3(3): 043.
  12. Kapur R, Kim M, Rebetz J, Takabe-French A, Kim N, Shanmugabhavananthan S, et al. Gastrointestinal flora dictates the biological response in murine transfusion related acute lung injury (TRALI). Blood 2017; 130: 766.
  13. Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics--approaching a definition. Am J Clin Nutr 2001; 73(2 Suppl): 361S-4S.
  14. Asadi M, Fazeli MR, Sabokbar A. growth inhibitory effect of lactocare on Vibrio cholerae. Iran J Pathol 2018; 13(3): 301-7.
  15. Virk HS, Wiersinga WJ. Current place of probiotics for VAP. Crit Care 2019; 23(1): 46.
  16. Zeng J, Wang CT, Zhang FS, Qi F, Wang SF, Ma S, et al. Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial. Intensive Care Med 2016; 42(6): 1018-28.
  17. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials. Crit Care Med 2010; 38(3): 954-62.
  18. Bonten MJM. Ventilator-associated pneumonia: Preventing the inevitable. Clin Infect Dis 2011; 52(1): 115-21.
  19. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: A blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010; 182(8): 1058-64.
  20. Banupriya B, Biswal N, Srinivasaraghavan R, Narayanan P, Mandal J. Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: An open-label randomized controlled trial. Intensive Care Med 2015; 41(4): 677-85.
  21. Mahmoodpoor A, Hamishehkar H, Asghari R, Abri R, Shadvar K, Sanaie S. Effect of a probiotic preparation on ventilator-associated pneumonia in critically Ill patients admitted to the intensive care unit: A prospective double-blind randomized controlled trial. Nutr Clin Pract 2019; 34(1): 156-62.
  22. Masjedi M, Raoufi S, Dabiri G, Yazdani M, Vatankhah P. Effects of a novel seven-species probiotic against oropharyngeal bacterial infestation in adult trauma intensive care unit patients. J Clin Anal Med 2017; 8(Suppl 4): 417-21.
Journal of Isfahan Medical School
Volume 37, Issue 529 - Serial Number 529
May and June 2019
Pages 593-600

  • Receive Date 26 May 2019
  • Accept Date 06 April 2022